856 Routine Baseline Blood Tests Predicting Pembrolizumab Sensitivity in Advanced High-Grade Serous Ovarian Cancer (AHGSOC) 1st Line Therapy: Substudy from the NEOPEMBROV/GINECO (NCT03275506) Randomized Trial
International Journal of Gynecological Cancer(2024)
关键词
Biomarkers for Immunotherapy,Immune Responses
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要